Yatharth Hospital & Trauma Care Services profit and loss

Latest FY26

Revenue: ₹1,207cr+37.1% on FY25
EBITDA: ₹292cr+32.6% on FY25
Net profit: ₹170cr+30.5% on FY25
EPS: ₹18.20+23.6% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Expenses
	1,334	1,207	880	671	372
	28.8	25.8	16.2	15.6	2.4
	1,363	1,233	897	686	373
	121	0.0	179	133	—
	129	234	0.0	0.0	—
	0.5	0.3	0.0	0.0	—
	265	235	163	117	60.5
	12.9	6.5	7.5	9.4	8.7
	101	87.8	57.2	29.3	12.6
	508	446	319	240	143
	1,138	1,009	725	529	288
	310	292	220	180	105
	209	204	163	151	92.7
Profit
	225	224	172	157	—
	0.0	0.0	0.0	0.0	85.5
	225	224	172	157	85.5
	54.4	52.6	49.2	40.3	21.9
	−3.8	0.7	−8.0	2.1	−0.7
	50.6	53.3	41.2	42.4	21.3
	174	170	131	114	64.2
	174	170	131	114	—
	0.9	0.6	0.3	0.1	0.2
	175	171	131	115	66.1
Per share
	₹18.80	₹18.20	₹14.72	₹14.46	₹9.83
	₹18.80	₹18.20	₹14.72	₹14.46	₹9.83
Other comprehensive income — detail
	0.9	0.6	0.3	—	—
	1.1	0.8	0.4	—	—
	0.3	0.2	0.1	—	—
	—	—	131	—	—
	—	—	0.0	—	—
Per share — as-filed variants
	₹18.80	₹18.20	₹14.72	₹14.46	—
	₹18.80	₹18.20	₹14.72	₹14.46	—
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	1,084	973	702	537	—
	81.2%	80.6%	79.7%	80.1%	—
Adjusted (ex-exceptional items) — derived
	225	224	172	157	—
	0.0	0.0	0.0	0.0	85.5
	174	170	131	114	—
	₹18.80	₹18.20	₹14.72	₹14.46	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

YATHARTH₹923.30

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersMAXHEALTH MEDANTA FORTIS VIYASH THYROCARE SUPRIYA STAR SPARCMcap ₹8,896 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	371.5	670.5	880.5	1,207.2	1,334.1
Other Income	2.4	15.6	16.2	25.8	28.8
Total Income	373.1	686.2	896.7	1,233.0	1,362.9
Expenses
+ Cost of Materials Consumed	—	133.3	178.5	0.0	121.0
+ Purchases of Stock-in-Trade	—	0.0	0.0	234.3	128.9
+ Changes in Inventories	—	0.0	0.0	0.3	0.5
+ Employee Benefit Expense	60.5	117.0	162.5	234.6	265.3
+ Finance Costs	8.7	9.4	7.5	6.5	12.9
+ Depreciation & Amortisation	12.6	29.3	57.2	87.8	101.1
+ Other Expenses	143.3	240.3	319.2	445.9	508.0
Total Expenses	287.6	529.3	724.9	1,009.4	1,137.8
EBITDA	105.3	179.9	220.2	292.1	310.4
EBIT	92.7	150.6	163.1	204.3	209.2
Profit
PBT before Exceptional Items	—	156.8	171.7	223.6	225.1
+ Exceptional Items	85.5	0.0	0.0	0.0	0.0
Pretax Income	85.5	156.8	171.7	223.6	225.1
+ Current Tax	21.9	40.3	49.2	52.6	54.4
+ Deferred Tax	-0.7	2.1	-8.0	0.7	-3.8
Tax Expense	21.3	42.4	41.2	53.3	50.6
Net Income	64.2	114.5	130.6	170.3	174.5
+ Net Income — Continuing Ops	—	114.5	130.6	170.3	174.5
+ Other Comprehensive Income	0.2	0.1	0.3	0.6	0.9
Total Comprehensive Income	66.1	114.6	130.8	170.9	175.3
Per Share
Basic EPS	9.83	14.46	14.72	18.20	18.80
Diluted EPS	9.83	14.46	14.72	18.20	18.80
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.3	0.6	0.9
+ Items NOT to be Reclassified to P&L	—	—	0.4	0.8	1.1
+ Tax on Items NOT to be Reclassified	—	—	0.1	0.2	0.3
Comprehensive Income — Owners of Parent	—	—	130.5	—	—
Comprehensive Income — Non-controlling Interests	—	—	0.0	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	—	14.46	14.72	18.20	18.80
Diluted EPS — Continuing Operations	—	14.46	14.72	18.20	18.80
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	—	537.2	702.0	972.6	1,083.7
Gross Margin %	—	80.12	79.72	80.57	81.23
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	—	156.8	171.7	223.6	225.1
− Exceptional Items (reconciliation)	85.5	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	—	114.5	130.6	170.3	174.5
EPS Adj	—	14.46	14.72	18.20	18.80
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	—	10.00	10.00	10.00	10.00
Paid Up Equity Capital	—	—	96.4	96.4	96.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.